BG
Bellevue Group Portfolio holdings
AUM
$4.54B
This Quarter Return
-16.23%
1 Year Return
+22.5%
3 Year Return
+98.22%
5 Year Return
+159.37%
10 Year Return
–
AUM
$1.45B
AUM Growth
+$1.45B
(-8%)
Cap. Flow
+$148M
Cap. Flow
% of AUM
10.17%
Top 10 Holdings %
Top 10 Hldgs %
37.98%
Holding
149
New
10
Increased
70
Reduced
43
Closed
11
Top Buys
| 1 |
Align Technology
ALGN
|
$34.4M |
| 2 |
Illumina
ILMN
|
$31.2M |
| 3 |
Intuitive Surgical
ISRG
|
$24.4M |
| 4 |
Teladoc Health
TDOC
|
$24.2M |
| 5 |
Abbott
ABT
|
$15.2M |
Top Sells
| 1 |
KTWO
K2M Group Holdings, Inc
KTWO
|
$15.1M |
| 2 |
Centene
CNC
|
$14.7M |
| 3 |
Edwards Lifesciences
EW
|
$14.6M |
| 4 |
Pacific Biosciences
PACB
|
$13.9M |
| 5 |
SHPG
Shire pic
SHPG
|
$11.6M |
Sector Composition
| 1 | Healthcare | 92.41% |
| 2 | Industrials | 1.04% |
| 3 | Technology | 0.54% |
| 4 | Financials | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Illumina
ILMN
$15.8B
| $75.6M | 4.97% | 251,893 +104,186 | +71% | +$31.2M |
|
|
2
Abbott
ABT
$231B
| $70.6M | 4.64% | 976,451 +209,741 | +27% | +$15.2M |
|
|
3
Intuitive Surgical
ISRG
$170B
| $66.5M | 4.37% | 138,797 +50,929 | +58% | +$24.4M |
|
|
4
Align Technology
ALGN
$10.3B
| $65.1M | 4.28% | 310,795 +164,485 | +112% | +$34.4M |
|
5
Elevance Health
ELV
$71.8B
| $61.1M | 4.02% | 232,660 +8,472 | +4% | +$2.22M |
|
|
6
Teladoc Health
TDOC
$1.37B
| $53.2M | 3.5% | 1,073,839 +487,319 | +83% | +$24.2M |
|
7
Medtronic
MDT
$119B
| $45.2M | 2.97% | 496,446 | – | – |
|
|
CELG
8
DELISTED
Celgene Corp
CELG
| $42.1M | 2.77% | 657,601 +51,601 | +9% | +$3.31M |
|
9
Boston Scientific
BSX
$156B
| $37.4M | 2.46% | 1,056,889 +77,960 | +8% | +$2.76M |
|
10
Danaher
DHR
$147B
| $34.3M | 2.26% | 332,896 +79,880 | +32% | +$8.24M |
|
11
UnitedHealth
UNH
$281B
| $33.1M | 2.18% | 132,836 +8,988 | +7% | +$2.24M |
|
12
Jazz Pharmaceuticals
JAZZ
$7.75B
| $32.3M | 2.12% | 260,648 +46,890 | +22% | +$5.81M |
|
13
Cigna
CI
$80.3B
| $31.5M | 2.07% | 165,625 -3,838 | -2% | -$729K |
|
14
Becton Dickinson
BDX
$55.3B
| $27.5M | 1.81% | 121,872 +16,459 | +16% | +$3.71M |
|
15
Bristol-Myers Squibb
BMY
$96B
| $25.3M | 1.66% | 486,824 +145,095 | +42% | +$7.54M |
|
|
16
Edwards Lifesciences
EW
$47.8B
| $24.2M | 1.59% | 157,797 -95,536 | -38% | -$14.6M |
|
17
Stryker
SYK
$150B
| $23.6M | 1.55% | 150,834 +9,454 | +7% | +$1.48M |
|
18
Humana
HUM
$36.5B
| $22.5M | 1.48% | 78,660 -19,850 | -20% | -$5.69M |
|
19
Esperion Therapeutics
ESPR
$448M
| $20.8M | 1.37% | 451,972 +60,120 | +15% | +$2.77M |
|
20
Ionis Pharmaceuticals
IONS
$6.8B
| $20.7M | 1.36% | 382,588 +72,052 | +23% | +$3.9M |
|
|
WCG
21
DELISTED
Wellcare Health Plans, Inc.
WCG
| $19.6M | 1.29% | 83,204 +54,935 | +194% | +$13M |
|
22
Vertex Pharmaceuticals
VRTX
$100B
| $19M | 1.25% | 114,700 +74,206 | +183% | +$12.3M |
|
|
WMGI
23
DELISTED
Wright Medical Group Inc
WMGI
| $18.5M | 1.21% | 678,114 +55,422 | +9% | +$1.51M |
|
24
Cencora
COR
$56.5B
| $18.4M | 1.21% | 246,762 +7,909 | +3% | +$588K |
|
|
HRC
25
DELISTED
HILL-ROM HOLDINGS, INC.
HRC
| $18.2M | 1.19% | 205,008 +19,319 | +10% | +$1.71M |
|